Short Seller Alleges ‘Aggressive’ Accounting Techniques by Ottobock

Why It Matters

The allegations raise regulatory and governance risks that could further depress Ottobock’s share price and expose minority shareholders to losses.

Key Takeaways

• Grizzly Research accuses Ottobock of aggressive R&D capitalization.
• CEO Hans York Nater allegedly extracted €2.3 bn via margin loan.
• Over 30% of net income tied to Russian market, per report.
• Company’s PIK loan restructuring hidden from shareholders, raising risk.
• Grizzly values Ottobock at ~$30 per share, far below market.

Summary

Grizzly Research has launched a scathing report on German prosthetics maker Ottobock, alleging that CEO Hans York Nater has used aggressive accounting tricks and a massive PIK loan to mask cash outflows and inflate earnings.

The short‑seller points to the capitalization of research‑and‑development costs, a €2.3 billion margin loan tied to a share‑buyback, and a restructuring that moved the loan’s maturity from 2028 to 2024, all of which it says were not fully disclosed to investors.

Grizzly also claims more than 30 % of Ottobock’s net income stems from its Russian business, a exposure that could evaporate if the Ukraine conflict ends, and cites high CFO turnover as a red flag.

The firm values Ottobock at roughly $30 per share—far below its current market price—suggesting the stock is overvalued and vulnerable to regulatory probes.

Original Description

Siegfried Eggert, CEO of Grizzly Research, discusses the short seller's findings on German prosthetic maker Ottobock. Grizzly alleges that majority shareholder Hans Georg Nader's margin loan and Russia business endanger public shareholders. Ottobock told CNBC they categorically reject the statements and claims made in the report, as well as the report’s overall conclusion.